Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 ALK, lung cancer, and personalized therapy: portent of the future?

× No keyword cloud information.

7 in total

Review 1. Family-based designs for genome-wide association studies.

Authors: Jurg Ott; Yoichiro Kamatani; Mark Lathrop
Journal: Nat Rev Genet Date: 2011-06-01 Impact factor: 53.242

2. Correlation Between E-cadherin Immunoexpression and Efficacy of First Line Platinum-Based Chemotherapy in Advanced High Grade Serous Ovarian Cancer.

Authors: Branka Petrić Miše; Vesna Dobrić Telesmanić; Snježana Tomić; Dinka Šundov; Vesna Čapkun; Eduard Vrdoljak
Journal: Pathol Oncol Res Date: 2014-08-11 Impact factor: 3.201

3. Epigenetic Therapy in Lung Cancer - Role of microRNAs.

Authors: Sacha I Rothschild
Journal: Front Oncol Date: 2013-06-19 Impact factor: 6.244

4. [A case report: an EML4-ALK positive lung adenocarcinoma diagnosed  with lymphoma previously].

Authors: Li Liu; Wei Heng
Journal: Zhongguo Fei Ai Za Zhi Date: 2015-02

5. Real-World Use and Outcomes of ALK-Positive Crizotinib-Treated Metastatic NSCLC in US Community Oncology Practices: A Retrospective Observational Study.

Authors: Craig Reynolds; Elizabeth T Masters; Jenny Black-Shinn; Marley Boyd; Jack Mardekian; Janet L Espirito; Marc Chioda
Journal: J Clin Med Date: 2018-05-29 Impact factor: 4.241

6. Real-World Outcomes Among Crizotinib-Treated Patients with ROS1-Positive Advanced Non-Small-Cell Lung Cancer: A Community Oncology-Based Observational Study.

Authors: David Waterhouse; Laura Iadeluca; Sneha Sura; Keith Wilner; Birol Emir; Stan Krulewicz; Janet Espirito; Lauren Bartolome
Journal: Target Oncol Date: 2021-12-29 Impact factor: 4.493

7. Clinical characteristics and risk factors of drug-induced lung injury by ALK tyrosine kinase inhibitors: A single center retrospective analysis.

Authors: Ken Koshikawa; Jiro Terada; Mitsuhiro Abe; Shunichiro Iwasawa; Masashi Sakayori; Keiichiro Yoshioka; Yasutaka Hirasawa; Hajime Kasai; Yohei Kawasaki; Kenji Tsushima; Koichiro Tatsumi
Journal: Thorac Cancer Date: 2020-04-01 Impact factor: 3.500